Intel (INTC) Benefiting from Datacenter, Better PC and iPhone, Baird Says; PT to $42
- Wall Street dips on Trump protectionism, Qualcomm drag
- Yahoo! (YHOO) Tops Q4 EPS by 4c; Sees Verizon Deal Closing in Q2, Not Q1
- Aetna's (AET) Humana (HUM) Takeover Blocked by Judge as Anticompetative
- Trump signs order withdrawing U.S. from Trans-Pacific trade deal
- After-Hours Stock Movers 1/23: (REXX) (MRCY) (SYNC) Higher; (FSM) (OCUL) (CASC) Lower (more...)
Get instant alerts when news breaks on your stocks. Claim your 2-week free trial to StreetInsider Premium here.
Baird analyst Tristan Gerra reiterated an Outperform rating and boosted estimates and his price target on Intel (NASDAQ: INTC) to $42.00 (from $40.00) after the company raised its Q3 revenue outlook.
The analyst notes the initial iPhone7 teardown shows Intel’s baseband inside and they estimate 40% market share and $12-$13 content. In addition, they continue to believe Intel will retain its market share position in the iPhone8. They believe engagement with Apple could eventually lead to a foundry partnership, a few years out.
"We think currently accelerating data center order momentum will help Intel’s outlook in 4Q and potentially continuing into 1Q17," Gerra commented. "Our initial PC unit outlook for 2017 is above consensus. Initial iPhone7 teardown shows Intel’s baseband inside. We continue to believe Intel will retain its market share position in the iPhone8, which should further and meaningfully reduce mobile losses in 2018."
The firm raised FY 2016 EPS from $2.00 to $2.05 and FY 2017 EPS from $2.42 to $2.45.
Shares of Intel closed at $36.56 yesterday.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- General Electric (GE) PT Lowered to $35 at UBS Following 4Q Report
- Bristol-Myers Squibb Co. (BMY) PT Lowered to $47 at BMO Capital; See Much Uncertainty and Increased Risk
- CytoSorbents (CTSO) PT Raised to $10 at Maxim Group
Create E-mail Alert Related CategoriesAnalyst Comments, Analyst EPS Change, Analyst PT Change
Related EntitiesRobert W Baird
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!